FibroGen Inc (FGEN) is near the top in its industry group according to InvestorsObserver. FGEN gets an overall rating of 68. That means it scores higher than 68 percent of stocks. FibroGen Inc gets a 86 rank in the Biotechnology industry. Biotechnology is number 28 out of 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 68 means the stock is more attractive than 68 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With FibroGen Inc Stock Today?
FibroGen Inc (FGEN) stock is trading at $41.85 as of 2:14 PM on Tuesday, Sep 29, a decline of -$1.16, or -2.7% from the previous closing price of $43.01. The stock has traded between $41.49 and $43.07 so far today. Volume today is below average. So far 433,442 shares have traded compared to average volume of 808,498 shares.
Click Here to get the full Stock Score Report on FibroGen Inc (FGEN) Stock.
